Christopher Gemski

Christopher Gemski is a Senior Research Scientist at Takeda Oncology, with over nine years of experience in translational research and biomarker assay development, focusing on oncology, gastrointestinal, central nervous system, and rare diseases. Key contributions include providing pharmacokinetic and pharmacodynamic data for regulatory filings and enhancing oral absorption through innovative in vitro dissolution systems. Previous roles have included Biologist I at Smithers Viscient, where supervisory responsibilities were undertaken, and Graduate Researcher at Rhode Island College, collaborating with multiple universities to study peptide synthesis related to neurodegenerative disorders. Christopher holds a Master's degree and Bachelor's degree in Biology from Rhode Island College.